44% Prior Auth Denial Rate at a Texas TMS Practice With Mid‑Treatment Reversals
Table of Contents
THE SITUATION
TMS therapy reimbursement depends entirely on prior authorization, and prior authorization for TMS depends on meeting each payer’s specific medical necessity criteria, which change frequently.
This Dallas practice had been providing TMS for three years. In mid-2023, their denial rate on TMS claims jumped from 11% to 44% in one quarter.
The clinical team hadn’t changed. The patients hadn’t changed. The payer rules had.
WHAT WAS ACTUALLY WRONG
BCBS TX added a failed medication trial requirement in January 2023:
BCBS TX updated their TMS medical necessity criteria in January 2023 to require documented trials of at least 4 adequate-dose antidepressant medications (not 2, as previously required). The practice was submitting auth requests documenting 2 trials, which had been sufficient under the old criteria. BCBS was approving auths and then reversing them at claim adjudication when clinical notes showed only 2 documented trials.
Aetna added a PHQ-9 score threshold requirement:
Aetna now requires a baseline PHQ-9 score of 15 or higher documented at the time of auth request. The practice was documenting PHQ-9 scores in the clinical record but not including them in the auth request submission. Aetna was approving auths and then denying claims when the PHQ-9 wasn’t on the clinical record submitted with the claim.
UHC’s site-of-service requirement changed for office-based TMS:
UHC updated their policy to require that office-based TMS claims include a specific place-of-service modifier. The practice’s AdvancedMD template wasn’t including it.
WHAT WE DID
Week 1: Pulled current TMS medical necessity criteria from BCBS TX, Aetna, and UHC. Built a payer-specific auth checklist for each required documentation, score thresholds, and medication trial requirements.
Week 2: Updated intake and pre-auth process so all new TMS patients receive medication trial documentation and PHQ-9 scoring at intake, formatted for auth submission.
Week 3: Updated AdvancedMD TMS billing template with UHC place-of-service modifier. Corrected all outstanding UHC claims.
Weeks 4–8: Filed appeals on all 2023 BCBS and Aetna denials where documentation supported the new criteria (medication trials existed in records, PHQ-9 scores documented, just not submitted with auth).
THE RESULTS
| Metric | Before | After |
|---|---|---|
| Auth-Related Denial Rate | 44% | 5% |
| Monthly Revenue Restored | — | $22,000 |
| Auth Approval Rate | 56% | 95% |
| BCBS TX Appeals Won | $0 | $67,000 |
| Aetna Appeals Won | $0 | $44,000 |
WHAT THIS MEANS FOR YOUR PRACTICE
TMS medical necessity criteria are updated more frequently than almost any other behavioral health service, and payers don’t notify providers of changes. If your TMS practice hasn’t reviewed BCBS, Aetna, and UHC criteria in the last 6 months, your auth process is likely operating on outdated requirements.